High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency.
Somech
Raz
R
Kavadas
Fotini D
FD
Atkinson
Adelle
A
Grunebaum
Eyal
E
Roifman
Chaim M
CM
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D018572:Disease-Free Survival; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D012189:Retrospective Studies; D016511:Severe Combined Immunodeficiency / Q000235:genetics / Q000401:mortality / Q000628:therapy*
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone